Associations between short-chain fatty acid levels and mood disorder symptoms: a systematic review

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Standard

Associations between short-chain fatty acid levels and mood disorder symptoms : a systematic review. / Bruun, Caroline Fussing; Hansen, Tue Haldor; Vinberg, Maj; Kessing, Lars Vedel; Coello, Klara.

I: Nutritional Neuroscience, Bind 27, Nr. 8, 2024, s. 899–912.

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Harvard

Bruun, CF, Hansen, TH, Vinberg, M, Kessing, LV & Coello, K 2024, 'Associations between short-chain fatty acid levels and mood disorder symptoms: a systematic review', Nutritional Neuroscience, bind 27, nr. 8, s. 899–912. https://doi.org/10.1080/1028415X.2023.2277970

APA

Bruun, C. F., Hansen, T. H., Vinberg, M., Kessing, L. V., & Coello, K. (2024). Associations between short-chain fatty acid levels and mood disorder symptoms: a systematic review. Nutritional Neuroscience, 27(8), 899–912. https://doi.org/10.1080/1028415X.2023.2277970

Vancouver

Bruun CF, Hansen TH, Vinberg M, Kessing LV, Coello K. Associations between short-chain fatty acid levels and mood disorder symptoms: a systematic review. Nutritional Neuroscience. 2024;27(8):899–912. https://doi.org/10.1080/1028415X.2023.2277970

Author

Bruun, Caroline Fussing ; Hansen, Tue Haldor ; Vinberg, Maj ; Kessing, Lars Vedel ; Coello, Klara. / Associations between short-chain fatty acid levels and mood disorder symptoms : a systematic review. I: Nutritional Neuroscience. 2024 ; Bind 27, Nr. 8. s. 899–912.

Bibtex

@article{6bbad0bdce94415f80241fd070672c77,
title = "Associations between short-chain fatty acid levels and mood disorder symptoms: a systematic review",
abstract = "Background: Available evidence points to a possible role of Short Chain Fatty Acids (SCFAs) in mood disorders. This is the first systematic review to map the associations between SCFA levels and mood disorder symptoms. Methods: Following the PRISMA guidelines, the databases PubMed, Embase, and PsycINFO were searched for studies that assessed SCFA levels in human populations with mood disorder symptoms, or animal models of mood disorder. Risk of bias was assessed by the Strengthening of Reporting of Observational Studies in Epidemiology (STROBE) checklist. Results: 19 studies were included and could be divided into animal (n=8) and human studies (n=11), with the animal studies including 166 animals and 100 controls, and the human studies including 662 participants and 330 controls. The studies were characterized by heterogeneity and methodological challenges on multiple parameters, limiting the validity and transferability of findings. Notably, only two of the clinical studies assessed the presence of mood disorder with diagnostic criteria, and no studies of mania or bipolar disorder met the inclusion criteria. Discussion: Despite significant methodological limitations, associations between SCFA levels and depressive symptoms were reported in most of the studies. However, the direction of these associations and the specific SCFAs identified varied. The quantification of SCFA levels in mood disorders is an emerging yet sparsely studied research field. Although there is some evidence suggesting a link between SCFAs and depressive symptoms, the directionality of effects and mechanisms are unclear and the relation to manic symptoms is uninvestigated.",
keywords = "Acetate, Affective disorders‌, Butyrate, Depression, Gut-brain-axis, Mood disorder, Propionate‌, Short chain fatty acids",
author = "Bruun, {Caroline Fussing} and Hansen, {Tue Haldor} and Maj Vinberg and Kessing, {Lars Vedel} and Klara Coello",
note = "Publisher Copyright: {\textcopyright} 2023 Informa UK Limited, trading as Taylor & Francis Group.",
year = "2024",
doi = "10.1080/1028415X.2023.2277970",
language = "English",
volume = "27",
pages = "899–912",
journal = "Nutritional Neuroscience",
issn = "1028-415X",
publisher = "Taylor & Francis",
number = "8",

}

RIS

TY - JOUR

T1 - Associations between short-chain fatty acid levels and mood disorder symptoms

T2 - a systematic review

AU - Bruun, Caroline Fussing

AU - Hansen, Tue Haldor

AU - Vinberg, Maj

AU - Kessing, Lars Vedel

AU - Coello, Klara

N1 - Publisher Copyright: © 2023 Informa UK Limited, trading as Taylor & Francis Group.

PY - 2024

Y1 - 2024

N2 - Background: Available evidence points to a possible role of Short Chain Fatty Acids (SCFAs) in mood disorders. This is the first systematic review to map the associations between SCFA levels and mood disorder symptoms. Methods: Following the PRISMA guidelines, the databases PubMed, Embase, and PsycINFO were searched for studies that assessed SCFA levels in human populations with mood disorder symptoms, or animal models of mood disorder. Risk of bias was assessed by the Strengthening of Reporting of Observational Studies in Epidemiology (STROBE) checklist. Results: 19 studies were included and could be divided into animal (n=8) and human studies (n=11), with the animal studies including 166 animals and 100 controls, and the human studies including 662 participants and 330 controls. The studies were characterized by heterogeneity and methodological challenges on multiple parameters, limiting the validity and transferability of findings. Notably, only two of the clinical studies assessed the presence of mood disorder with diagnostic criteria, and no studies of mania or bipolar disorder met the inclusion criteria. Discussion: Despite significant methodological limitations, associations between SCFA levels and depressive symptoms were reported in most of the studies. However, the direction of these associations and the specific SCFAs identified varied. The quantification of SCFA levels in mood disorders is an emerging yet sparsely studied research field. Although there is some evidence suggesting a link between SCFAs and depressive symptoms, the directionality of effects and mechanisms are unclear and the relation to manic symptoms is uninvestigated.

AB - Background: Available evidence points to a possible role of Short Chain Fatty Acids (SCFAs) in mood disorders. This is the first systematic review to map the associations between SCFA levels and mood disorder symptoms. Methods: Following the PRISMA guidelines, the databases PubMed, Embase, and PsycINFO were searched for studies that assessed SCFA levels in human populations with mood disorder symptoms, or animal models of mood disorder. Risk of bias was assessed by the Strengthening of Reporting of Observational Studies in Epidemiology (STROBE) checklist. Results: 19 studies were included and could be divided into animal (n=8) and human studies (n=11), with the animal studies including 166 animals and 100 controls, and the human studies including 662 participants and 330 controls. The studies were characterized by heterogeneity and methodological challenges on multiple parameters, limiting the validity and transferability of findings. Notably, only two of the clinical studies assessed the presence of mood disorder with diagnostic criteria, and no studies of mania or bipolar disorder met the inclusion criteria. Discussion: Despite significant methodological limitations, associations between SCFA levels and depressive symptoms were reported in most of the studies. However, the direction of these associations and the specific SCFAs identified varied. The quantification of SCFA levels in mood disorders is an emerging yet sparsely studied research field. Although there is some evidence suggesting a link between SCFAs and depressive symptoms, the directionality of effects and mechanisms are unclear and the relation to manic symptoms is uninvestigated.

KW - Acetate

KW - Affective disorders‌

KW - Butyrate

KW - Depression

KW - Gut-brain-axis

KW - Mood disorder

KW - Propionate‌

KW - Short chain fatty acids

U2 - 10.1080/1028415X.2023.2277970

DO - 10.1080/1028415X.2023.2277970

M3 - Review

C2 - 37976103

AN - SCOPUS:85177023713

VL - 27

SP - 899

EP - 912

JO - Nutritional Neuroscience

JF - Nutritional Neuroscience

SN - 1028-415X

IS - 8

ER -

ID: 376460704